Cytokinetics
CYTK
#2280
Rank
S$10.40 B
Marketcap
S$85.10
Share price
-1.31%
Change (1 day)
24.52%
Change (1 year)

Cytokinetics (CYTK) - Total debt

Total debt on the balance sheet as of September 2025 : S$1.55 Billion

According to Cytokinetics 's latest financial reports the company's total debt is S$1.55 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Cytokinetics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$1.07 B7.4%
2023-12-31S$0.99 B-0.77%
2022-12-31S$1.00 B175.64%
2021-12-31S$0.36 B98.54%
2020-12-31S$0.18 B0.2%
2019-12-31S$0.18 B210.94%
2018-12-31S$58.99 M38.81%
2017-12-31S$42.5 M-1.72%
2016-12-31S$43.24 M108.85%
2015-12-31S$20.7 M
2012-12-31N/A-100%
2011-12-31S$0.19 M-84.49%
2010-12-31S$1.26 M-92.94%
2009-12-31S$17.97 M170.85%
2008-12-31S$6.63 M-46.93%
2007-12-31S$12.5 M-24.74%
2006-12-31S$16.61 M6.59%
2005-12-31S$15.58 M-8.94%
2004-12-31S$17.11 M-0.07%
2003-12-31S$17.13 M4.01%
2002-12-31S$16.47 M152.4%
2001-12-31S$6.52 M248.94%
2000-12-31S$1.87 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Ligand Pharmaceuticals
LGND
S$0.58 B-62.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
S$48.67 M-96.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$0.25 B-83.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$70.73 B 4,460.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S$0.88 B-43.10%๐Ÿ‡บ๐Ÿ‡ธ USA